Skip to main content

Zura Bio Ltd

ZURA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001855644

No open-market purchases or sales by Zura Bio Ltd insiders were filed in the last 90 days; 95 institutions reported holding it in 13F filings for Q2 2026, worth $428.9M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Zura Bio Ltd insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Zura Bio Ltd, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Zura Bio Ltd
NameTitleLast reported holdingLast filingFilings, past year
Munshi AmitDirector777,384Jun 22, 20261
Jarrett JenniferDirector–Jun 22, 20261
Becker Daniel J.Director–Jun 22, 20261
Eisner MarkDirector–Jun 22, 20262
Schoch Steven JDirector–Jun 22, 20261
Thiara ParvinderDirector0IndirectJun 22, 20262
Nirula AjayDirector–Jun 22, 20262
Kulkarni Sandeep ChidambarChief Executive Officer–Apr 2, 20262
Davis KimChief Legal Officer1,500IndirectApr 2, 20261
Whale GaryChief Technology Officer–Apr 2, 20261
Hyllengren Eric JChief Financial Officer–Apr 2, 20261
Nistala KiranSee Remarks3,195Apr 2, 20261
Blavatnik Len10% Owner6,552,725Mar 2, 20261
Access Industries Holdings LLC10% Owner6,552,725Mar 2, 20261
Access Industries Management, LLC10% Owner6,552,725Mar 2, 20261
AI Biotechnology LLC10% Owner6,552,725Mar 2, 20261
Sidhu SomeitDirector2,085,418May 22, 20250
Ploos van Amstel ArnoutDirector100,000May 22, 20250
Graham Neil Murray HamiltonDirector–May 22, 20250
Badial Verender S.Chief Financial Officer–May 12, 20250
Lisicki RobertChief Executive Officer–Mar 3, 20250
Howell MichaelSee Remarks7,987IndirectSep 6, 20240
Athanor Capital, LP10% Owner–Jun 22, 20230
Neil Garry ArthurDirector–May 22, 20230
Cabell ChristopherCMO & Head of R&D162,060May 22, 20230
Barclays PLC10% Owner–Mar 31, 20230
Altman Jeffrey A10% Owner0IndirectMar 23, 20230
Owl Creek Asset Management, L.P.10% Owner0IndirectMar 23, 20230
JATT Ventures, L.P.10% Owner967,370Feb 15, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 2, 2026 (view filing)5:55 PM ETFeb 264 daysBlavatnik Len and 3 others10% OwnerPPurchaseClass A Ordinary Shares+2.00M$6.25+$12.5M+43.9%6.55M after
Nov 27, 2024 (view filing)Nov 252 daysThiara ParvinderDirectorSSaleClass A Ordinary Shares−1.00M$2.73−$2.73M−100.0%0 after
Sep 13, 2024 (view filing)Sep 112 daysThiara ParvinderDirectorSSaleClass A Ordinary Shares−3.80M$2.70−$10.3M−79.1%1.00M after
Sep 6, 2024 (view filing)Sep 42 daysSidhu SomeitDirectorSSaleClass A ordinary shares−51.7K$3.87−$200.2K−2.4%2.09M after
May 23, 2024 (view filing)May 176 daysLatePloos van Amstel ArnoutDirectorPPurchaseClass A ordinary shares+80.0K$6.20+$496.0K+400.0%100.0K after
Dec 14, 2023 (view filing)Dec 122 daysThiara ParvinderDirector, 10% OwnerSSaleClass A Ordinary Shares−2.00M$4.00−$8.00M−29.4%4.80M after
Dec 13, 2023 (view filing)Dec 112 daysSidhu SomeitChief Executive OfficerPPurchaseClass A Ordinary Shares+1.75M–––1.75M afterDerivative
Jun 22, 2023 (view filing)5:21 PM ETJun 157 daysLateAthanor Capital, LP10% OwnerSSaleClass A Ordinary Shares−1.19M$0.25−$298.5K–0 afterDerivative
Jun 5, 2023 (view filing)Jun 5Same dayMunshi AmitDirectorPPurchaseClass A Ordinary Shares+117.6K$4.25+$500.0K+23.5%617.6K after